Schrodinger, Inc. (SDGR, Financial) saw its stock price decline by 5% to $20.99 per share. Trading volume reached 626,922 shares, with a turnover rate of 0.86% and a price fluctuation amplitude of 6.34%.
In its latest financial report, Schrodinger recorded $35.29 million in revenue, a net loss of $38.14 million, and an earnings per share of -$0.52. The company reported a gross profit of $17.73 million and a price-to-earnings ratio of -8.58. Out of 11 rating agencies, 73% recommended buying the stock, while 27% suggested holding. No agencies advised selling.
Within the health information services sector, the overall decline was 0.71%. Notable stocks include Onemednet Corp, Bullfrog Ai Holdings Inc, and Logicmark, Inc., which experienced significant trading activity. Logicmark, Inc. had a turnover rate of 185.17%, and a notable price fluctuation of 25.71%.
Schrodinger, Inc. is a healthcare software company focusing on software and drug discovery. It generates revenue by selling software solutions and through collaborations on research funding and drug discovery milestones.
